NON-ALCOHOLIC STEATOHEPATITIS
Clinical trials for NON-ALCOHOLIC STEATOHEPATITIS explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC STEATOHEPATITIS trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC STEATOHEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a diabetes drug tame fatty liver disease?
Disease control OngoingThis study tests semaglutide, a diabetes medicine, in 1205 adults with non-cirrhotic NASH (a type of fatty liver disease). Participants inject the drug or a placebo once weekly for about 5 years. The goal is to see if semaglutide can reverse liver inflammation and scarring withou…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
New scanner aims to spot fatty liver without needles
Diagnosis TerminatedThis study was designed to test a new device that uses sound and heat to measure fat in the liver. It would compare the device's accuracy to standard MRI scans in adults with or suspected of having non-alcoholic fatty liver disease. The goal was to see if this simpler method coul…
Matched conditions: NON-ALCOHOLIC STEATOHEPATITIS
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated May 26, 2026 04:13 UTC